{"id":127175,"date":"2023-02-21T16:33:42","date_gmt":"2023-02-21T16:33:42","guid":{"rendered":"http:\/\/pressarabia.qa\/?guid=c386c79d58075298262594a66ee896c6"},"modified":"2023-02-21T16:33:42","modified_gmt":"2023-02-21T16:33:42","slug":"ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab","status":"publish","type":"post","link":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/","title":{"rendered":"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB"},"content":{"rendered":"

NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) —\u00a0WHY:\u00a0<\/strong>Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, both dates inclusive (the \u201cClass Period\u201d), of the important\u00a0March 20, 2023 lead plaintiff deadline<\/strong>.<\/p>\n

SO WHAT:<\/strong>\u00a0If you purchased Y-mAbs securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.<\/p>\n

WHAT TO DO NEXT:\u00a0<\/strong>To join the Y-mAbs class action, go to\u00a0https:\/\/rosenlegal.com\/submit-form\/?case_id=9496<\/a>\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\u00a0pkim@rosenlegal.com<\/a>\u00a0or\u00a0cases@rosenlegal.com<\/a>\u00a0for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court\u00a0no later than March 20, 2023<\/strong>. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.<\/p>\n

WHY ROSEN LAW:\u00a0<\/strong>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition.\u00a0Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases.<\/strong>\u00a0Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs\u2019 Bar. Many of the firm\u2019s attorneys have been recognized by Lawdragon and Super Lawyers.<\/p>\n

DETAILS OF THE CASE:\u00a0<\/strong>According to the Complaint, the Company made false and misleading statements to the market. Y-mAbs repeatedly misled investors about its meetings with the FDA, claiming that it was making progress in demonstrating the effectiveness and efficacy of its drug candidate, omburtamab. What was unknown to investors was that the FDA had repeatedly advised Y-mAbs that the treatment of effect of omburtamab cannot be objectively established or quantified based on a comparison between Study 03-133 and an external cohort comprised of data from the Central German Childhood Cancer Registry (CGCCR) database because of substantial differences in the patient populations, and the absence of tumor response data, and that Study 101 was neither sufficiently advanced nor indicative of efficacy to justify approval. Further, Y-mAbs failed to advise investors that it had elected to submit the March 31, 2022 BLA prior to reaching agreement with the FDA on the content of the application. Based on these facts, the Company\u2019s public statements were false and materially misleading throughout the class period. When the market learned the truth about Y-mAbs, investors suffered damages.<\/p>\n

To join the Y-mAbs class action, go to\u00a0https:\/\/rosenlegal.com\/submit-form\/?case_id=9496<\/a>\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\u00a0pkim@rosenlegal.com<\/a>\u00a0or\u00a0cases@rosenlegal.com<\/a>\u00a0for information on the class action.<\/p>\n

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor\u2019s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.<\/p>\n

Follow us for updates on LinkedIn:\u00a0https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>, on Twitter:\u00a0https:\/\/twitter.com\/rosen_firm<\/a>\u00a0or on Facebook:\u00a0https:\/\/www.facebook.com\/rosenlawfirm\/<\/a>.<\/p>\n

Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n

Contact Information:<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Laurence Rosen, Esq.
\nPhillip Kim, Esq.
\nThe Rosen Law Firm, P.A.
\n275 Madison Avenue, 40th Floor
\nNew York, NY 10016
\nTel: (212) 686-1060
\nToll Free: (866) 767-3653
\nFax: (212) 202-3827
\nlrosen@rosenlegal.com<\/a>
\npkim@rosenlegal.com<\/a>
\ncases@rosenlegal.com<\/a>
\nwww.rosenlegal.com<\/a><\/p>\n

GlobeNewswire Distribution ID 8753674<\/p>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) \u2014\u00a0WHY:\u00a0Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, both dates inclusive (the \u201cClass Period\u201d), of the important\u00a0March 20, 2023 lead plaintiff deadline. SO WHAT:\u00a0If you purchased Y-mAbs securities [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"\nYMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB - Press Arabia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB - Press Arabia\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) \u2014\u00a0WHY:\u00a0Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, both dates inclusive (the \u201cClass Period\u201d), of the important\u00a0March 20, 2023 lead plaintiff deadline. SO WHAT:\u00a0If you purchased Y-mAbs securities [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/\" \/>\n<meta property=\"og:site_name\" content=\"Press Arabia\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-21T16:33:42+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/person\/b57865692031dadc763e08ddab1bd9f2\"},\"headline\":\"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB\",\"datePublished\":\"2023-02-21T16:33:42+00:00\",\"dateModified\":\"2023-02-21T16:33:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/\"},\"wordCount\":721,\"publisher\":{\"@id\":\"https:\/\/pressarabia.qa\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/\",\"url\":\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/\",\"name\":\"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB - Press Arabia\",\"isPartOf\":{\"@id\":\"https:\/\/pressarabia.qa\/#website\"},\"datePublished\":\"2023-02-21T16:33:42+00:00\",\"dateModified\":\"2023-02-21T16:33:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pressarabia.qa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pressarabia.qa\/#website\",\"url\":\"https:\/\/pressarabia.qa\/\",\"name\":\"Press Arabia\",\"description\":\"Arab News Headlines\",\"publisher\":{\"@id\":\"https:\/\/pressarabia.qa\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pressarabia.qa\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pressarabia.qa\/#organization\",\"name\":\"Press Arabia\",\"url\":\"https:\/\/pressarabia.qa\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pressarabia.qa\/wp-content\/uploads\/2022\/08\/cropped-press-arabia.png\",\"contentUrl\":\"https:\/\/pressarabia.qa\/wp-content\/uploads\/2022\/08\/cropped-press-arabia.png\",\"width\":200,\"height\":129,\"caption\":\"Press Arabia\"},\"image\":{\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/person\/b57865692031dadc763e08ddab1bd9f2\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pressarabia.qa\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/pressarabia.qa\/author\/admin01\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB - Press Arabia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/","og_locale":"en_US","og_type":"article","og_title":"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB - Press Arabia","og_description":"NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) \u2014\u00a0WHY:\u00a0Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, both dates inclusive (the \u201cClass Period\u201d), of the important\u00a0March 20, 2023 lead plaintiff deadline. SO WHAT:\u00a0If you purchased Y-mAbs securities [\u2026]","og_url":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/","og_site_name":"Press Arabia","article_published_time":"2023-02-21T16:33:42+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/#article","isPartOf":{"@id":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/"},"author":{"name":"admin","@id":"https:\/\/pressarabia.qa\/#\/schema\/person\/b57865692031dadc763e08ddab1bd9f2"},"headline":"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB","datePublished":"2023-02-21T16:33:42+00:00","dateModified":"2023-02-21T16:33:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/"},"wordCount":721,"publisher":{"@id":"https:\/\/pressarabia.qa\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/","url":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/","name":"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB - Press Arabia","isPartOf":{"@id":"https:\/\/pressarabia.qa\/#website"},"datePublished":"2023-02-21T16:33:42+00:00","dateModified":"2023-02-21T16:33:42+00:00","breadcrumb":{"@id":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pressarabia.qa\/ymab-loss-alert-rosen-top-ranked-national-investor-attorneys-encourages-y-mabs-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ymab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pressarabia.qa\/"},{"@type":"ListItem","position":2,"name":"YMAB LOSS ALERT: ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 YMAB"}]},{"@type":"WebSite","@id":"https:\/\/pressarabia.qa\/#website","url":"https:\/\/pressarabia.qa\/","name":"Press Arabia","description":"Arab News Headlines","publisher":{"@id":"https:\/\/pressarabia.qa\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pressarabia.qa\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pressarabia.qa\/#organization","name":"Press Arabia","url":"https:\/\/pressarabia.qa\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pressarabia.qa\/#\/schema\/logo\/image\/","url":"https:\/\/pressarabia.qa\/wp-content\/uploads\/2022\/08\/cropped-press-arabia.png","contentUrl":"https:\/\/pressarabia.qa\/wp-content\/uploads\/2022\/08\/cropped-press-arabia.png","width":200,"height":129,"caption":"Press Arabia"},"image":{"@id":"https:\/\/pressarabia.qa\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pressarabia.qa\/#\/schema\/person\/b57865692031dadc763e08ddab1bd9f2","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pressarabia.qa\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/pressarabia.qa\/author\/admin01\/"}]}},"_links":{"self":[{"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/posts\/127175"}],"collection":[{"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/comments?post=127175"}],"version-history":[{"count":0,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/posts\/127175\/revisions"}],"wp:attachment":[{"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/media?parent=127175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/categories?post=127175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pressarabia.qa\/wp-json\/wp\/v2\/tags?post=127175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}